New MicroRNA-Based Diagnostic Test Now Commercially Available
Rosetta Genomics, Ltd has announced the commercial availability of its second diagnostic test, miRview mets. The test is now commercially available through Rosetta Genomics CLIA-certified lab in Philadelphia.
Read More